Adenosine Receptor A2B Negatively Regulates Cell Migration in Ovarian Carcinoma Cells.

Anaí Del Rocío Campos-Contreras, Adriana González-Gallardo, Mauricio Díaz-Muñoz, Francisco G Vázquez-Cuevas

International journal of molecular sciences 2022 Apr 21

filter terms:

The purinergic system is fundamental in the tumor microenvironment, since it regulates tumor cell interactions with the immune system, as well as growth and differentiation in autocrine-paracrine responses. Here, we investigated the role of the adenosine A2B receptor (A2BR) in ovarian carcinoma-derived cells' (OCDC) properties. From public databases, we documented that high A2BR expression is associated with a better prognostic outcome in ovarian cancer patients. In vitro experiments were performed on SKOV-3 cell line to understand how A2BR regulates the carcinoma cell phenotype associated with cell migration. RT-PCR and Western blotting revealed that the ADORA2B transcript (coding for A2BR) and A2BR were expressed in SKOV-3 cells. Stimulation with BAY-606583, an A2BR agonist, induced ERK1/2 phosphorylation, which was abolished by the antagonist PSB-603. Pharmacological activation of A2BR reduced cell migration and actin stress fibers; in agreement, A2BR knockdown increased migration and enhanced actin stress fiber expression. Furthermore, the expression of E-cadherin, an epithelial marker, increased in BAY-606583-treated cells. Finally, cDNA microarrays revealed the pathways mediating the effects of A2BR activation on SKOV-3 cells. Our results showed that A2BR contributed to maintaining an epithelial-like phenotype in OCDC and highlighted this purinergic receptor as a potential biomarker.

Citation

Anaí Del Rocío Campos-Contreras, Adriana González-Gallardo, Mauricio Díaz-Muñoz, Francisco G Vázquez-Cuevas. Adenosine Receptor A2B Negatively Regulates Cell Migration in Ovarian Carcinoma Cells. International journal of molecular sciences. 2022 Apr 21;23(9)